You have 9 free searches left this month | for more free features.

Condition

Lymphoma, Non-Hodgkin (2)

Leukemia, Lymphocytic, Chronic, B-Cell (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Janssen Research & Development, LLC (2)

Collaborator

Intervention

jnj-80948543 (2)

jnj-75348780 (1)

jnj-87801493 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

jnj-80948543

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting

Lymphoma, Non-Hodgkin

JNJ-87801493
+2 more

(no location specified)

Nov 15, 2023

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-80948543)

Recruiting

Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell

JNJ-80948543

Duarte, California
+18 more

Aug 11, 2022